These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38691868)

  • 21. NDUFA8 is transcriptionally regulated by EP300/H3K27ac and promotes mitochondrial respiration to support proliferation and inhibit apoptosis in cervical cancer.
    Xiang H; Tang H; He Q; Sun J; Yang Y; Kong L; Wang Y
    Biochem Biophys Res Commun; 2024 Jan; 693():149374. PubMed ID: 38096616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2F1-EP300 co-activator complex potentiates immune escape in nasopharyngeal carcinoma through the mediation of MELK.
    Wang Q; Yu Q; Liu Y
    Histol Histopathol; 2024 Apr; 39(4):511-523. PubMed ID: 37728155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells.
    Yang J; Huang H; Xiao D; Duan Y; Zheng Y; Chen Z
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of EP300 and DDR1 synergistically alleviates pulmonary fibrosis in vitro and in vivo.
    Tao J; Zhang M; Wen Z; Wang B; Zhang L; Ou Y; Tang X; Yu X; Jiang Q
    Biomed Pharmacother; 2018 Oct; 106():1727-1733. PubMed ID: 30119248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation.
    Garcia-Carpizo V; Ruiz-Llorente S; Sarmentero J; Graña-Castro O; Pisano DG; Barrero MJ
    Epigenetics Chromatin; 2018 Jun; 11(1):30. PubMed ID: 29884215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.
    Osaka E; Yang X; Shen JK; Yang P; Feng Y; Mankin HJ; Hornicek FJ; Duan Z
    J Orthop Res; 2014 Aug; 32(8):1075-82. PubMed ID: 24760686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer.
    Xiang Q; Wang C; Zhang Y; Xue X; Song M; Zhang C; Li C; Wu C; Li K; Hui X; Zhou Y; Smaill JB; Patterson AV; Wu D; Ding K; Xu Y
    Eur J Med Chem; 2018 Mar; 147():238-252. PubMed ID: 29448139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.
    Thanindratarn P; Dean DC; Nelson SD; Hornicek FJ; Duan Z
    Cell Prolif; 2020 Oct; 53(10):e12901. PubMed ID: 32960500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neogenin-1 Promotes Cell Proliferation, Motility, and Adhesion by Up-Regulation of Zinc Finger E-Box Binding Homeobox 1 Via Activating the Rac1/PI3K/AKT Pathway in Gastric Cancer Cells.
    Qu H; Sun H; Wang X
    Cell Physiol Biochem; 2018; 48(4):1457-1467. PubMed ID: 30064133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SETD1A-mediated H3K4me3 methylation upregulates lncRNA HOXC-AS3 and the binding of HOXC-AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells.
    Shi Z; Zhang H; Shen Y; Zhang S; Zhang X; Xu Y; Sun D
    Thorac Cancer; 2023 Sep; 14(25):2579-2590. PubMed ID: 37548102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of p300 in the tumor progression of oral squamous cell carcinoma.
    Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
    J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
    Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of survivin in sacral chordoma.
    Chen C; Yang HL; Chen KW; Wang GL; Lu J; Yuan Q; Gu YP; Luo ZP
    Med Oncol; 2013 Jun; 30(2):529. PubMed ID: 23504337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer.
    Bemanian V; Noone JC; Sauer T; Touma J; Vetvik K; Søderberg-Naucler C; Lindstrøm JC; Bukholm IR; Kristensen VN; Geisler J
    Breast Cancer Res Treat; 2018 Nov; 172(2):339-351. PubMed ID: 30132219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
    Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
    Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular features and vulnerabilities of recurrent chordomas.
    Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
    J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-oncogenic mechanism of KLF17 in colon cancer by repressing cell migration and invasion via FHL1 upregulation.
    Yi S; Luo M; Peng Y; Chen Y; Yu D
    Chin J Physiol; 2023; 66(6):534-545. PubMed ID: 38149566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.
    Wu KJ; Zeng J; Zhu GD; Zhang LL; Zhang D; Li L; Fan JH; Wang XY; He DL
    Acta Pharmacol Sin; 2009 Aug; 30(8):1162-8. PubMed ID: 19578386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA LINC00525 interacts with miR-31-5p and miR-125a-5p to act as an oncogenic molecule in spinal chordoma.
    Gong F; Wang X; Sun Q; Su X; Hu X; Liu B
    Biochem Biophys Res Commun; 2021 Jan; 536():80-87. PubMed ID: 33370717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300.
    Williams LM; McCann FE; Cabrita MA; Layton T; Cribbs A; Knezevic B; Fang H; Knight J; Zhang M; Fischer R; Bonham S; Steenbeek LM; Yang N; Sood M; Bainbridge C; Warwick D; Harry L; Davidson D; Xie W; Sundstrӧm M; Feldmann M; Nanchahal J
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20753-20763. PubMed ID: 32759223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.